Achieving Systemic Delivery of Oncolytic Viruses

Expert Opinion on Drug Delivery - United Kingdom
doi 10.1080/17425247.2019.1617269
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Oncolytic Virotherapy: Molecular Targets in Tumor-Selective Replication and Carrier Cell-Mediated Delivery of Oncolytic Viruses

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2008English

Micromanaging Oncolytic Viruses

Science-Business eXchange
2008English

Oncolytic Viruses: Overcoming Translational Challenges

Journal of Clinical Investigation
Medicine
2019English

Oncolytic Viruses: Immune or Cytolytic Therapy?

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Sensitivity of Breast Tumors to Oncolytic Viruses

2005English

Potential and Clinical Translation of Oncolytic Measles Viruses

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

Delivery and Biosafety of Oncolytic Virotherapy

Frontiers in Oncology
Cancer ResearchOncology
2020English

Oncolytic Viruses: A Step Into Cancer Immunotherapy

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Comparison of Safety, Delivery, and Efficacy of Two Oncolytic Herpes Viruses (G207 and NV1020) for Peritoneal Cancer

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy